Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000347
Filing Date
2025-04-25
Accepted
2025-04-25 16:07:19
Documents
44
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q restez10q063024.htm   iXBRL 10-Q 261766
2 EXHIBIT 3.6 restezex3-6.htm EX-3.6 35985
3 EXHIBIT 31.1 restezex31-1.htm EX-31.1 12645
4 EXHIBIT 31.2 restezex31-2.htm EX-31.2 12565
5 EXHIBIT 32.1 restezex32-1.htm EX-32.1 6261
6 EXHIBIT 32.2 restezex32-2.htm EX-32.2 7238
7 GRAPHIC ex3-6_001.jpg GRAPHIC 5871
  Complete submission text file 0001185185-25-000347.txt   1718743

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE rest-20240630.xsd EX-101.SCH 13845
9 XBRL CALCULATION FILE rest-20240630_cal.xml EX-101.CAL 13898
10 XBRL DEFINITION FILE rest-20240630_def.xml EX-101.DEF 51750
11 XBRL LABEL FILE rest-20240630_lab.xml EX-101.LAB 105314
12 XBRL PRESENTATION FILE rest-20240630_pre.xml EX-101.PRE 62750
47 EXTRACTED XBRL INSTANCE DOCUMENT restez10q063024_htm.xml XML 87077
Mailing Address 1398 WEST MASON HOLLOW DRIVE RIVERTON UT 84065
Business Address 1398 WEST MASON HOLLOW DRIVE RIVERTON UT 84065 801-300-2542
REST EZ Inc. (Filer) CIK: 0001733861 (see all company filings)

EIN.: 824268982 | State of Incorp.: WY | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-56447 | Film No.: 25873968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)